Publication | Closed Access
A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model
21
Citations
33
References
2015
Year
Tumor ImmunologyGp100 Tumor AntigenCancer ImmunosurveillanceMulti-trimeric FusionImmunologyTherapeutic VaccineImmunotherapyMedicineCell BiologyTumor BiologyDendritic Cells
| Year | Citations | |
|---|---|---|
Page 1
Page 1